![]() |
市場調查報告書
商品編碼
2070378
拋棄式內視鏡市場規模、佔有率、成長、全球產業分析、區域洞察及2026-2034年預測Disposable Endoscopes Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
全球拋棄式視鏡市場規模在2025年為31億美元,預計將從2026年的35.3億美元成長至2034年的103億美元,預測期內複合年成長率(CAGR)為14.3%。拋棄式內視鏡是一種單次使用的微創醫療設備,用於胃腸病學、呼吸內科、泌尿系統、耳鼻喉科、整形外科和其他臨床領域的診斷和治療。
由於人們對醫院感染的擔憂日益加劇、感染控制指南日益嚴格,以及對無菌一次性醫療器材的需求不斷成長,該市場正在蓬勃發展。這些內視鏡無需重複處理,並降低了交叉感染的風險。到2025年,北美將以38.38%的市佔率引領全球市場。
市場趨勢
拋棄式內視鏡技術的快速發展是市場的關鍵趨勢。各公司正在不斷改進影像品質、設備操作性、工作通道、數位連接性和感測器整合。這些改進正在縮小可重複使用內視鏡和拋棄式內視鏡之間的效能差距。
2024 年 5 月,Ambu 的「aScope Gastro Large」獲得了 FDA 的批准,其改進的工作通道有助於提高治療程序中的臨床效能。
市場促進因素
人們對感染控制日益成長的關注是推動市場成長的主要因素。可重複使用的內視鏡需要複雜的清潔和再處理流程,但仍有污染風險。而拋棄式內視鏡則透過每次檢查使用無菌設備,提高了病患安全性並降低了感染風險。監管機構的支持和醫院安全規程也進一步促進了一次性內視鏡的普及。
市場限制因素
高昂的治療費用是主要的阻礙因素。拋棄式內視鏡每次手術都需要持續採購,增加了醫院和診所的營運成本。相較之下,可重複使用的內視鏡雖然初始成本較高,但可以重複使用。尤其是在新興國家,預算限制和保險報銷問題可能會限制其普及。
市場機遇
新興市場醫療保健投資的增加帶來了巨大的機會。亞太地區和拉丁美洲的醫療基礎設施正在不斷改進,感染控制意識日益增強,對微創手術的需求也不斷成長。此外,消化器官系統和呼吸系統疾病病例的增加也推動了對拋棄式視鏡的需求。
2021 年 1 月,印度 AIG 醫院開始使用一次性十二指腸內視鏡,這標誌著在亞洲引入該技術邁出了重要一步。
市場挑戰
新興國家熟練專業人員短缺仍然是一個挑戰。雖然一次性器械降低了感染風險,但進行檢查仍需要訓練有素的內視鏡醫師和輔助人員。缺乏訓練項目和技術專長會影響檢查效率,並延緩先進內視鏡技術的普及應用。
區域分析
預計北美將引領全球市場,到 2025 年將達到 11.9 億美元,高於 2024 年的 10.4 億美元。美國市場預計到 2026 年將達到 11.8 億美元,約佔全球銷售額的 33.4%。
預計到2026年,亞太地區市場規模將達到6.6億美元,成為第二大區域市場。其中,預計到2026年,中國市場規模將達到2.8億美元,日本市場規模將達1.4億美元,印度市場規模將達到1.1億美元。
預計2026年,歐洲市場規模將達到10.4億美元,預測期內年平均成長率預估為13.3%。到2026年,英國市場規模預計將達到1.9億美元,德國市場規模預計將達2.5億美元。
由於醫療基礎設施的改善和先進醫療技術的廣泛應用,預計到2026年,拉丁美洲醫療保健市場規模將達到2.3億美元。海灣合作理事會(GCC)市場預計到2026年將達到7,000萬美元。
The global disposable endoscopes market was valued at USD 3.10 billion in 2025 and is projected to grow from USD 3.53 billion in 2026 to USD 10.30 billion by 2034, registering a CAGR of 14.3% during the forecast period. Disposable endoscopes are single-use, minimally invasive medical devices used for diagnostic and therapeutic procedures in gastroenterology, pulmonology, urology, ENT, orthopedics, and other clinical areas.
The market is growing due to rising concerns over Hospital-Acquired Infections, strict infection-control guidelines, and increasing preference for sterile single-use devices. These endoscopes eliminate the need for reprocessing and reduce cross-contamination risks. North America dominated the global market in 2025 with a 38.38% market share.
Market Trends
A major market trend is the rapid technological advancement in disposable endoscopes. Companies are improving image quality, device maneuverability, working channels, digital connectivity, and sensor integration. These improvements are narrowing the performance gap between reusable and disposable scopes.
In May 2024, Ambu's aScope Gastro Large received FDA clearance with an improved working channel, supporting better clinical performance in therapeutic procedures.
Market Drivers
Rising infection-control concerns are a key driver of market growth. Reusable endoscopes require complex cleaning and reprocessing, yet contamination risks may still remain. Disposable endoscopes provide a sterile device for every procedure, improving patient safety and reducing infection risks. Regulatory support and hospital safety protocols are further encouraging adoption.
Market Restraints
High procedural cost is a major restraint. Disposable endoscopes require continuous procurement for every procedure, increasing operating expenses for hospitals and clinics. In comparison, reusable endoscopes involve high upfront cost but can be used repeatedly. Budget constraints and reimbursement challenges, especially in emerging countries, may restrict adoption.
Market Opportunities
Rising healthcare investments in emerging markets offer strong opportunities. Asia Pacific and Latin America are witnessing improvements in healthcare infrastructure, growing awareness of infection control, and rising demand for minimally invasive procedures. Increasing cases of gastrointestinal and respiratory disorders are also supporting demand for single-use endoscopes.
In January 2021, AIG Hospitals in India began using disposable duodenoscopes, marking an important step for adoption in Asia.
Market Challenges
Shortage of skilled professionals in emerging countries remains a challenge. Although disposable devices reduce infection risk, procedures still require trained endoscopists and support staff. Limited training programs and lack of technical expertise can affect procedural efficiency and slow adoption of advanced endoscopic technologies.
Segment Analysis
By product, the market is segmented into bronchoscopes, gastrointestinal endoscopes, ureteroscopes, and others. The gastrointestinal endoscope segment held the largest market share in 2025 due to the high volume of colonoscopy and gastroscopy procedures worldwide. The bronchoscope segment is projected to grow at a CAGR of 13.8% during the forecast period.
By application, the market is classified into gastroenterology, pulmonology, urology, orthopedics, and others. The gastroenterology segment dominated in 2025 due to the rising burden of digestive diseases and frequent use of endoscopy for diagnosis and treatment. The segment is expected to hold 35.1% share in 2026. The pulmonology segment is projected to grow at a CAGR of 13.5%.
By end user, the market includes hospitals & ASCs, specialty clinics, and others. Hospitals & ASCs dominated in 2025 due to high procedural volumes, strong infection-control focus, and preference for patient safety. This segment is expected to hold 70.5% share in 2026. Specialty clinics are projected to grow at a CAGR of 15.4%.
Regional Analysis
North America led the global market with USD 1.19 billion in 2025, increasing from USD 1.04 billion in 2024. The U.S. market is expected to reach USD 1.18 billion in 2026, accounting for approximately 33.4% of global revenue.
Asia Pacific is projected to reach USD 0.66 billion in 2026, becoming the second-largest regional market. China is expected to reach USD 0.28 billion, Japan USD 0.14 billion, and India USD 0.11 billion in 2026.
Europe is projected to reach USD 1.04 billion in 2026, growing at a 13.3% rate during the forecast period. The U.K. market is expected to reach USD 0.19 billion, while Germany is projected at USD 0.25 billion in 2026.
Latin America is estimated to reach USD 0.23 billion in 2026, supported by healthcare infrastructure improvements and rising adoption of advanced medical technologies. The GCC market is projected to reach USD 0.07 billion in 2026.
Competitive Landscape
The market is competitive, with leading companies focusing on product expansion, FDA clearances, innovation, digital imaging, and strategic partnerships. Key players include Boston Scientific Corporation, PENTAX Medical, Ambu A/S, Integrated Endoscopy, UroViu Corporation, CooperSurgical, Flexicare, Welch Allyn/Baxter, Olympus Corporation, and OTU Medical. Boston Scientific, Olympus, and Ambu held the highest market share in 2025 due to their broad single-use endoscope portfolios.
Key Industry Developments
In May 2025, Olympus received FDA 510(k) clearance for its EZ1500 series endoscopes. In July 2024, Ambu received FDA clearance for aScope 5 Uretero. In April 2024, Olympus launched Vathin E-SteriScope in the U.S. for ENT procedures. In April 2024, Ambu received FDA clearance for aScope Gastro Large. In September 2021, Boston Scientific launched EXALT Model D Duodenoscope and EXALT Model B Bronchoscope.
Conclusion
The disposable endoscopes market is expected to grow from USD 3.10 billion in 2025 to USD 3.53 billion in 2026, reaching USD 10.30 billion by 2034. Growth will be driven by infection-control concerns, minimally invasive procedure demand, regulatory support, and technology improvements. However, high per-procedure costs and skilled workforce shortages may challenge wider adoption.
Segmentation By Product, Application, End-user, and Region
By Product * Bronchoscope
By Application * Gastroenterology
By End-user * Hospitals & ASCs
By Region * North America (By Product, Application, End-user, and Country)